Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$26.15 - $77.24 $1.4 Million - $4.14 Million
-53,539 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$60.18 - $154.77 $2.79 Million - $7.17 Million
-46,329 Reduced 46.39%
53,539 $3.87 Million
Q3 2019

Nov 07, 2019

SELL
$140.29 - $189.96 $852,542 - $1.15 Million
-6,077 Reduced 5.74%
99,868 $14 Million
Q2 2019

Aug 14, 2019

SELL
$157.85 - $183.09 $2.33 Million - $2.7 Million
-14,750 Reduced 12.22%
105,945 $19.4 Million
Q1 2019

May 09, 2019

SELL
$89.33 - $163.65 $9.9 Million - $18.1 Million
-110,788 Reduced 47.86%
120,695 $19.2 Million
Q4 2018

Feb 11, 2019

SELL
$81.94 - $139.71 $787,935 - $1.34 Million
-9,616 Reduced 3.99%
231,483 $22.2 Million
Q3 2018

Nov 07, 2018

SELL
$138.11 - $169.04 $2.59 Million - $3.17 Million
-18,729 Reduced 7.21%
241,099 $34.1 Million
Q2 2018

Aug 13, 2018

SELL
$140.36 - $175.76 $2.78 Million - $3.49 Million
-19,831 Reduced 7.09%
259,828 $40.7 Million
Q1 2018

May 14, 2018

SELL
$152.15 - $192.33 $10.2 Million - $12.9 Million
-66,938 Reduced 19.31%
279,659 $45 Million
Q4 2017

Feb 13, 2018

SELL
$60.72 - $167.34 $23.7 Million - $65.3 Million
-390,112 Reduced 52.95%
346,597 $57.1 Million
Q3 2017

Nov 07, 2017

BUY
$61.4 - $88.52 $419,669 - $605,034
6,835 Added 0.94%
736,709 $45.9 Million
Q2 2017

Aug 10, 2017

BUY
N/A
729,874
729,874 $58.1 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $284M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.